Title |
CancerGD: A Resource for Identifying and Interpreting Genetic Dependencies in Cancer
|
---|---|
Published in |
Cell Systems, July 2017
|
DOI | 10.1016/j.cels.2017.06.002 |
Pubmed ID | |
Authors |
Stephen Bridgett, James Campbell, Christopher J. Lord, Colm J. Ryan |
Abstract |
Genes whose function is selectively essential in the presence of cancer-associated genetic aberrations represent promising targets for the development of precision therapeutics. Here, we present CancerGD, a resource that integrates genotypic profiling with large-scale loss-of-function genetic screens in tumor cell lines to identify such genetic dependencies. CancerGD provides tools for searching, visualizing, and interpreting these genetic dependencies through the integration of functional interaction networks. CancerGD includes different screen types (siRNA, shRNA, CRISPR), and we describe a simple format for submitting new datasets. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Ireland | 4 | 15% |
United States | 3 | 12% |
United Kingdom | 2 | 8% |
Switzerland | 1 | 4% |
Brazil | 1 | 4% |
Portugal | 1 | 4% |
Australia | 1 | 4% |
Unknown | 13 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 13 | 50% |
Scientists | 10 | 38% |
Science communicators (journalists, bloggers, editors) | 2 | 8% |
Practitioners (doctors, other healthcare professionals) | 1 | 4% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 76 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 20 | 26% |
Researcher | 17 | 22% |
Student > Bachelor | 7 | 9% |
Professor | 5 | 7% |
Student > Master | 5 | 7% |
Other | 10 | 13% |
Unknown | 12 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 29 | 38% |
Agricultural and Biological Sciences | 18 | 24% |
Computer Science | 5 | 7% |
Immunology and Microbiology | 3 | 4% |
Medicine and Dentistry | 2 | 3% |
Other | 5 | 7% |
Unknown | 14 | 18% |